Caraco

Caraco Stockholders Approve Merger With Parent Sun Pharma

Detroit-based Caraco Pharmaceutical Laboratories Inc. will shortly cease operation as a publicly traded company.

WWJ Newsradio 950–2011/06/14

Caraco Announces $5.25-A-Share Deal With Sun Pharma

Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) said Tuesday that it had entered into a merger agreement Monday with Sun Pharmaceutical Industires Ltd., an Indian pharma firm that already owns 75.8 percent of Caraco’s stock.

2011/02/22

Caraco Loss Flat Despite Lower Sales

The Detroit generic drug maker Caraco Pharmaceutical reported a loss of $3 million or eight cents a share in the third fiscal quarter of its fiscal year, ended Dec. 31, an improvement from a loss of $3.3 million or eight cents a share in the same quarter a year earlier despite a decline in revenue in the quarter to $40.4 million from $52 million a year earlier.

2011/01/30

Caraco Sets Independent Committee To Study Buyout Offer

A day after receiving a buyout offer from its Indian parent company for the minority of its shares still on the public markets, the Detroit generic drugmaker appoints a group to study the offer

2010/12/07

Caraco Gets Sun Pharma Offer To Go Private

Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) has received an offer to go private from its parent company and India.

WWJ Newsradio 950–2010/12/06

Caraco Pharmaceutical Names New CEO

Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) announced last week that G. P. Singh Sachdeva will assume the position of CEO following the resignation of Jitendra N. Doshi as interim CEO and director as […]

2010/10/10

Caraco Markets Generic Flomax

Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) said Thursday that it had started shipping tamsulosin hydrochloride capsules. This product was recently approved by the United States Food and Drug Administration from an Abbreviated New […]

2010/07/22

Caraco Markets Generic Wellbutrin

Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) said Wednesday that it had started shipping bupropion hydrochloride extended release tablets.

2010/07/21

Caraco Adds Two Generics

Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) announced that it has started shipping azelastine ophthalmic solution, 0.05 percent, and rivastigmine tartrate capsules.

2010/07/18

Listen Live!